We are live on ! Find out more
ELEV

Elevation Oncology

Delisted

ELEV was delisted on the 22nd of July, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
TCM
1
Tang Capital Management
California
$2.65M
Millennium Management
2
Millennium Management
New York
$2.01M +$724K +715,788 +31%
VP
3
venBio Partners
California
$1.93M
ACM
4
Aisling Capital Management
New York
$1.88M
QUSVM
5
Qiming U.S. Ventures Management
Washington
$1.57M
BI
6
BVF Inc
California
$1.53M
O
7
OrbiMed
New York
$994K
IC
8
Ikarian Capital
Texas
$777K +$22.7K +22,449 +2%
Vanguard Group
9
Vanguard Group
Pennsylvania
$709K -$5.41K -5,352 -0.5%
ECM
10
ExodusPoint Capital Management
New York
$662K -$505K -499,773 -33%
SFM
11
Sphera Funds Management
Israel
$596K
Citadel Advisors
12
Citadel Advisors
Florida
$557K +$1.63K +1,607 +0.2%
AC
13
Armistice Capital
New York
$497K -$1.66M -1,646,000 -69%
Hudson Bay Capital Management
14
Hudson Bay Capital Management
Connecticut
$362K
VCIM
15
Velan Capital Investment Management
Georgia
$330K
DCM
16
DAFNA Capital Management
California
$298K
Two Sigma Investments
17
Two Sigma Investments
New York
$291K +$14.9K +14,693 +3%
BFM
18
Boothbay Fund Management
New York
$170K +$22.7K +22,449 +10%
Geode Capital Management
19
Geode Capital Management
Massachusetts
$153K +$95K +93,971 +69%
Bank of America
20
Bank of America
North Carolina
$102K +$156K +154,447 +15,444,700%
Walleye Capital
21
Walleye Capital
New York
$98.7K +$45.8K +45,257 +44%
UBS Group
22
UBS Group
Switzerland
$82.6K +$110K +108,483 +675%
Two Sigma Advisers
23
Two Sigma Advisers
New York
$50.9K +$77.7K +76,800 New
BCM
24
Bridgeway Capital Management
Texas
$37.4K
Goldman Sachs
25
Goldman Sachs
New York
$37K +$56.5K +55,878 New